{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:08Z","timestamp":1791389048651,"version":"4.3.3"},"reference-count":125,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PRIAM-based consortium of multiple funders"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Peyote (Lophophora williamsii) is a cactus that contains various biologically active alkaloids\u2014such as pellotine, anhalonidine, hordenine and mescaline. Here, mescaline induces the psychoactive effects of peyote through the activation of the serotonin 5-HT2A receptor and the subsequent release of calcium (Ca2+) from the endoplasmic reticulum (ER). Moreover, an evaluation of the therapeutic benefits of mescaline is also currently the subject of research. It is important to consider that the outcome of taking a psychedelic drug strongly depends on the mindset of the recipient and the context (set and setting principle), including ceremonies and culture. This overview serves to summarise the current state of the knowledge of the metabolism, mechanism of action and clinical application studies of peyote and mescaline. Furthermore, the benefits of the potential of peyote and mescaline are presented in a new light, setting an example for combining a form of treatment embedded in nature and ritually enriched with our current highly innovative Western medicine.<\/jats:p>","DOI":"10.3390\/molecules28247942","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T02:55:32Z","timestamp":1701744932000},"page":"7942","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture"],"prefix":"10.3390","volume":"28","author":[{"given":"Marjolein","family":"Doesburg-van Kleffens","sequence":"first","affiliation":[{"name":"Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Campus Rosental\u2013Mattenstrasse 22, CH-4058 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8641-5965","authenticated-orcid":false,"given":"Amy M.","family":"Zimmermann-Klemd","sequence":"additional","affiliation":[{"name":"Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Campus Rosental\u2013Mattenstrasse 22, CH-4058 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Gr\u00fcndemann","sequence":"additional","affiliation":[{"name":"Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Campus Rosental\u2013Mattenstrasse 22, CH-4058 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"ref_1","unstructured":"Sahag\u00fan, B., and Bustamante, C.M. (1829). Historia General de las Cosas de Nueva Espa\u00f1a, Imprenta del Ciudadano Alejandro Vald\u00e9s."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF01826536","article-title":"Ueber Anhalonium lewinii und andere Cacteen","volume":"34","author":"Lewin","year":"1894","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lumholtz, C. (2011). Unknown Mexico: A Record of Five Years\u2019 Exploration among the Tribes of the Western Sierra Madre, Cambridge University Press.","DOI":"10.1017\/CBO9781139060547"},{"key":"ref_4","unstructured":"Stork, C.M. (2023). Reference Module in Biomedical Sciences, Elsevier."},{"key":"ref_5","unstructured":"(New York Times, 1964). The \u2018Diabolic Root\u2019, New York Times."},{"key":"ref_6","unstructured":"(2023, October 17). US Drug Enforcement Administration Drug Scheduling, Available online: https:\/\/web.archive.org\/web\/20081020210309\/http:\/\/www.usdoj.gov\/dea\/pubs\/scheduling.html."},{"key":"ref_7","unstructured":"(2023, October 17). International Narcotics Control Board List of Psychotropic Substances under International Control. Available online: https:\/\/web.archive.org\/web\/20051205125434\/http:\/\/www.incb.org\/pdf\/e\/list\/green.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nutt, D. (2015). Illegal drugs laws: Clearing a 50-year-old obstacle to research. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002047"},{"key":"ref_9","unstructured":"(2023, October 17). 103d United States Congress American Indian Religious Freedom Act Amendments, Available online: https:\/\/www.congress.gov\/103\/statute\/STATUTE-108\/STATUTE-108-Pg3125.pdf."},{"key":"ref_10","unstructured":"(2023, October 17). Decriminalize Nature\u2014Organizer Info & Resources. Available online: https:\/\/www.decriminalizenature.org\/policy\/organizer-info-and-resources."},{"key":"ref_11","unstructured":"Shulgin, A.T., and Shulgin, A. (1991). A Chemical Love Story, Transform Press Berkeley."},{"key":"ref_12","unstructured":"Pollan, M. (New York Times, 2021). How Should We Do Drugs Now?, New York Times."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/13634615211038416","article-title":"Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement","volume":"59","author":"Ona","year":"2021","journal-title":"Transcult. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02862854","article-title":"Early peyote research an interdisciplinary study","volume":"28","author":"Bruhn","year":"1973","journal-title":"Econ. Bot."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1021\/jm970219x","article-title":"Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives","volume":"40","author":"Monte","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/1570159X14666161031144427","article-title":"Herbal Highs: Review on Psychoactive Effects and Neuropharmacology","volume":"15","author":"Graziano","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1038\/sj.npp.1395318","article-title":"Serotonin and hallucinogens","volume":"21","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref_18","first-page":"46","article-title":"Mescaline: The chemistry and pharmacology of its analogs","volume":"36","author":"Shulgin","year":"1973","journal-title":"Lloydia"},{"key":"ref_19","first-page":"45","article-title":"Hallucinogens and Serotonin 5-HT(2A) Receptor-Mediated Signaling Pathways","volume":"36","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","article-title":"Multiplicity of mechanisms of serotonin receptor signal transduction","volume":"92","author":"Raymond","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","article-title":"Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada","volume":"239","author":"Leung","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_23","first-page":"w14463","article-title":"Medical use of cannabis in Switzerland: Analysis of approved exceptional licences","volume":"147","author":"Kilcher","year":"2017","journal-title":"Swiss Med. Wkly."},{"key":"ref_24","first-page":"452","article-title":"Prevalence and Social Acceptability of Cannabis, Tobacco, and Alcohol Use in Adult Women","volume":"2","author":"Coughenour","year":"2021","journal-title":"Womens Health Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1082183","DOI":"10.3389\/fpubh.2022.1082183","article-title":"Projecting the chronic disease burden among the adult population in the United States using a multi-state population model","volume":"10","author":"Ansah","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_26","unstructured":"(2023, October 17). World Health Organization Mental Disorders. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders."},{"key":"ref_27","unstructured":"(2023, October 17). Statista Global Drug Use\u2014Statistics & Facts. Available online: https:\/\/www.statista.com\/topics\/7786\/global-drug-use\/#topicOverview."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2850.2011.01831.x","article-title":"The physical health of the seriously mentally ill: An overview of the literature","volume":"19","author":"Collins","year":"2012","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3928\/0279-3695-19990601-15","article-title":"Health status risk factors of people with severe and persistent mental illness","volume":"37","author":"Farnam","year":"1999","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: Where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_31","first-page":"A14","article-title":"The vital link between chronic disease and depressive disorders","volume":"2","author":"Chapman","year":"2005","journal-title":"Prev. Chronic Dis."},{"key":"ref_32","unstructured":"Bauml, J.A., Schaefer, S.B., Labate, B.C., and Cavnar, C. (2016). Peyote: History, Tradition, Politics, and Conservation, Bloomsbury Publishing."},{"key":"ref_33","unstructured":"Laing, R.R. (2003). Hallucinogens: A Forensic Drug Handbook, Academic Press."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00413101","article-title":"Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions","volume":"3","author":"Wolbach","year":"1962","journal-title":"Psychopharmacologia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00403349","article-title":"Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception","volume":"4","author":"Hartman","year":"1963","journal-title":"Psychopharmacologia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005053-196001000-00005","article-title":"Lysergic acid diethylamide: Side effects and complications","volume":"130","author":"Cohen","year":"1960","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01567467","article-title":"Studies on mescaline I. Action in schizophrenic patients: Clinical observations and brain wave patterns, showing effects before and after electric convulsive treatments","volume":"29","author":"Denber","year":"1955","journal-title":"Psychiatr. Q."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0165-1781(89)90081-4","article-title":"Right hemisphere involvement in mescaline-induced psychosis","volume":"29","author":"Oepen","year":"1989","journal-title":"Psychiatry Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0006-3223(92)90059-9","article-title":"Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research","volume":"32","author":"Hermle","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-979352","article-title":"Blood flow and cerebral laterality in the mescaline model of psychosis","volume":"31","author":"Hermle","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.acc.2016.07.004","article-title":"Chapter Five\u2014Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse","volume":"78","author":"Dasgupta","year":"2017","journal-title":"Adv. Clin. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/jps.2600591202","article-title":"Peyote constituents: Chemistry, biogenesis, and biological effects","volume":"59","author":"Kapadia","year":"1970","journal-title":"J. Pharm. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cumming, P., Scheidegger, M., Dornbierer, D., Palner, M., Quednow, B.B., and Martin-Soelch, C. (2021). Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules, 26.","DOI":"10.3390\/molecules26092451"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00421558","article-title":"Autoradiographic studies on the distribution of 3H-mescaline in the brain of the marmoset, Callithrix jacchus","volume":"46","author":"Korr","year":"1976","journal-title":"Psychopharmacologia"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1874467211666181010154139","article-title":"Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions","volume":"12","author":"Pereira","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-2952(80)90337-8","article-title":"Prediction of mescaline clearance by rabbit lung and liver from enzyme kinetic data","volume":"29","author":"Hilliker","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-2952(74)90417-1","article-title":"Oxidative metabolism of mescaline in the central nervous system. 3. Side chain degradation of mescaline and formation of 3,4,5-trimethoxy-benzoic acid in vivo","volume":"23","author":"Seiler","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0006-2952(67)90268-7","article-title":"The metabolism of mescaline-14-C in rats","volume":"16","author":"Musacchio","year":"1967","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00427703","article-title":"Metabolic fate of mescaline in man","volume":"9","author":"Charalampous","year":"1966","journal-title":"Psychopharmacologia"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Dasgupta, A. (2019). Critical Issues in Alcohol and Drugs of Abuse Testing, Academic Press. [2nd ed.].","DOI":"10.1016\/B978-0-12-815607-0.00001-0"},{"key":"ref_51","first-page":"242","article-title":"Metabolic fate of \u03bd-(3,4,5-trimethoxyphenyl)-ethylamine (mescaline) in humans: Isolation and identification of 3,4,5-trimethoxyphenylacetic acid","volume":"145","author":"Charalampous","year":"1964","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-007-0926-5","article-title":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","volume":"196","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.01.014","article-title":"Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice","volume":"70","author":"Halberstadt","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Patel, V., Urban, L., and Vaz, R.J. (2015). Antitargets and Drug Safety, John Wiley & Sons.","DOI":"10.1002\/9783527673643"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109294","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: The forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: The involvement of MAP kinases","volume":"86","author":"Parrish","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","article-title":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction","volume":"278","author":"Xia","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","article-title":"PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors","volume":"29","author":"Abbas","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Weisstaub","year":"2007","journal-title":"Neuron"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Yuen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(83)90544-7","article-title":"Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors","volume":"96","author":"Trulson","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"ref_65","unstructured":"(2023, November 13). National Center for Biotechnology Information PubChem Compound Summary for CID 4076, Mescaline, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Mescaline."},{"key":"ref_66","unstructured":"Zechmeister, L. (1950). Fortschritte der Chemie organischer Naturstoffe, Springer."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.8b00215","article-title":"Dark Classics in Chemical Neuroscience: Mescaline","volume":"9","author":"Cassels","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/jm060656o","article-title":"1-Aminomethylbenzocycloalkanes: Conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists","volume":"49","author":"McLean","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ibarra-Laclette, E., Zamudio-Hern\u00e1ndez, F., P\u00e9rez-Torres, C.A., Albert, V.A., Ram\u00edrez-Ch\u00e1vez, E., Molina-Torres, J., Fern\u00e1ndez-Cortes, A., Calder\u00f3n-V\u00e1zquez, C., Olivares-Romero, J.L., and Herrera-Estrella, A. (2015). De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis. BMC Genom., 16.","DOI":"10.1186\/s12864-015-1821-9"},{"key":"ref_70","first-page":"129","article-title":"\u00dcber die Anhalonium-Alkaloide: I. Anhalin und Mezcalin","volume":"40","year":"1919","journal-title":"Monatshefte F\u00fcr Chem. Und Verwandte Teile Anderer Wiss."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cber.19300631117","article-title":"\u00dcber \u03b2-Phenyl-\u00e4thylamine, I. Mitteil.: Mezcalin und mezcalin-\u00e4hnliche Substanzen","volume":"63","author":"Slotta","year":"1930","journal-title":"Berichte Der Dtsch. Chem. Ges. (A B Ser.)"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ardp.19312693504","article-title":"\u00dcber neue und \u00fcber verbesserte Wege zum Aufbau von pharmakologisch wichtigen Aminen III. \u00dcber die Synthese von Adrenalin und von adrenalin\u00e4hnlichen Verbindungen","volume":"269","author":"Kindler","year":"1931","journal-title":"Arch. Der Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ardp.19322700709","article-title":"\u00dcber neue und \u00fcber verbesserte Wege zum Aufbau von pharmakologisch wichtigen Aminen VI. \u00dcber Synthesen des Meskalins","volume":"270","author":"Kindler","year":"1932","journal-title":"Arch. Der Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/cber.19340670430","article-title":"\u00dcber \u03b2-[Oxyphenyl]-\u00e4thylamine und ihre Umwandlungen, I. Mitteil.: Synthese des Mezcalins","volume":"67","author":"Hahn","year":"1934","journal-title":"Berichte Der Dtsch. Chem. Ges. (A B Ser.)"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hlca.19500330420","article-title":"\u00dcber die Reduktion von \u03b2-Nitrostyrolen mit Lithiumaluminiumhydrid","volume":"33","author":"Erne","year":"1950","journal-title":"Helv. Chim. Acta"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hlca.19520350519","article-title":"Notiz \u00fcber eine neue Synthese von Mezcalin, N-Methyl-und N-Dimethylmezcalin","volume":"35","author":"Banholzer","year":"1952","journal-title":"Helv. Chim. Acta"},{"key":"ref_77","first-page":"693","article-title":"Mescaline synthesis via tricarbonyl (\u03b76-1, 2, 3-trimethoxybenzene) chromium complex","volume":"300","author":"Chavignon","year":"2000","journal-title":"Inorganica Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1021\/op0601262","article-title":"Reductive cleavage of acetals and ketals with 9-borabicyclo[3.3. 1]nonane","volume":"10","author":"Soderquist","year":"2006","journal-title":"Org. Process Res. Dev."},{"key":"ref_79","unstructured":"B\u00e4umle, S. (2006). Heilpflanzenpraxis Heute: Portr\u00e4ts\u2014Rezepturen\u2014Anwendung, Urban & Fischer by Elsevier."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.2042-3306.1990.tb04312.x","article-title":"Hordenine: Pharmacology, pharmacokinetics and behavioural effects in the horse","volume":"22","author":"Frank","year":"1990","journal-title":"Equine Vet. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00216-016-9324-3","article-title":"A sensitive method for the determination of hordenine in human serum by ESI\u207a UPLC-MS\/MS for forensic toxicological applications","volume":"408","author":"Steiner","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jafc.7b05035","article-title":"Hordenine: A Novel Quorum Sensing Inhibitor and Antibiofilm Agent against Pseudomonas aeruginosa","volume":"66","author":"Zhou","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_83","first-page":"1121","article-title":"Ueber Pellotin","volume":"9","author":"Pilcz","year":"1896","journal-title":"Klin. Wochenschr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1021\/acs.jnatprod.1c00381","article-title":"The Alkaloids from Lophophora diffusa and Other \u201cFalse Peyotes\u201d","volume":"84","author":"Chan","year":"2021","journal-title":"J. Nat. Prod."},{"key":"ref_85","first-page":"45","article-title":"Report on the use of pellotine as a sedative and hypnotic","volume":"2","author":"Hutchings","year":"1897","journal-title":"State Hosp. Bull."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF01757452","article-title":"Die Wirkung des Pellotin im Kindesalter","volume":"13","year":"1934","journal-title":"Klin. Wochenschr."},{"key":"ref_87","first-page":"6","article-title":"Visions of the Night-Western Medicine Meets Peyote 1887\u20131899","volume":"2","author":"Perrine","year":"2001","journal-title":"Heffter Rev. Psychedelic Res"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acsptsci.3c00142","article-title":"In Vitro and In Vivo Evaluation of Pellotine: A Hypnotic Lophophora Alkaloid","volume":"6","author":"Poulie","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0028-3908(93)90097-M","article-title":"Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission","volume":"32","author":"Ghansah","year":"1993","journal-title":"Neuropharmacology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005053-195707000-00014","article-title":"The effects of mescaline sulfate in chronic schizophrenia","volume":"125","author":"Merlis","year":"1957","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/ajp.131.11.1247","article-title":"Peyote in the treatment of alcoholism among American Indians","volume":"131","author":"Albaugh","year":"1974","journal-title":"Am. J. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","article-title":"Psychological and cognitive effects of long-term peyote use among Native Americans","volume":"58","author":"Halpern","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acsptsci.1c00018","article-title":"Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes","volume":"4","author":"Haas","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/02698811211013583","article-title":"The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects","volume":"36","author":"Uthaug","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"ref_95","unstructured":"(2023, October 13). United States National Library of Medicine ClinicalTrials.gov\u2014Search Results: Mescaline, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05180149?intr=Mescaline&rank=6."},{"key":"ref_96","unstructured":"Feest, C.F. (1998). Beseelte Welten: Die Religionen der Indianer Nordamerikas, Herder."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-8741(82)90016-2","article-title":"Medicinal and other uses of the Compositae by Indians in the United States and Canada","volume":"5","author":"Shemluck","year":"1982","journal-title":"J. Ethnopharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10282580701677477","article-title":"The Native American Church, peyote, and health: Expanding consciousness for healing purposes","volume":"10","author":"Jones","year":"2007","journal-title":"Contemp. Justice Rev."},{"key":"ref_99","unstructured":"(2023, October 10). Ronald Reagan Presidential Library Digital Library Collections Folder Title: Native American Church of North America, Available online: https:\/\/www.reaganlibrary.gov\/public\/digitallibrary\/smof\/publicliaison\/blackwell\/box-038\/40_047_7007844_038_007_2017.pdf."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/00958964.2020.1726266","article-title":"Learning from a more-than-human perspective. Plants as teachers","volume":"51","author":"Carvalho","year":"2020","journal-title":"J. Environ. Educ."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mastinu, A., Anyanwu, M., Carone, M., Abate, G., Bonini, S.A., Peron, G., Tirelli, E., Pucci, M., Ribaudo, G., and Oselladore, E. (2023). The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021329"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13674670412331304348","article-title":"The American Indian Church and its sacramental use of peyote: A review for professionals in the mental-health arena","volume":"8","author":"Jones","year":"2005","journal-title":"Ment. Health Relig. Cult."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.pp.21.060170.003035","article-title":"The botanical and chemical distribution of hallucinogens","volume":"21","author":"Schultes","year":"1970","journal-title":"Annu. Rev. Plant Physiol."},{"key":"ref_104","unstructured":"Furst, P.T. (1972). Flesh of the Gods, Praeger Publishers."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/02791072.1998.10399709","article-title":"Hallucinogenic drugs and plants in psychotherapy and shamanism","volume":"30","author":"Metzner","year":"1998","journal-title":"J. Psychoact. Drugs"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1525\/maq.2000.14.4.521","article-title":"Jesus, peyote, and the holy people: Alcohol abuse and the ethos of power in Navajo healing","volume":"14","author":"Garrity","year":"2000","journal-title":"Med. Anthr. Q."},{"key":"ref_107","first-page":"3","article-title":"Native American Church Peyotism and the Treatment of Alcoholism","volume":"7","author":"McClusky","year":"1997","journal-title":"Newsl. Multidiscip. Assoc. Psychedelic Stud. MAPS"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/104365969400500202","article-title":"The Peyote way: Implications for Culture Care theory","volume":"5","author":"Huttlinger","year":"1994","journal-title":"J. Transcult. Nurs."},{"key":"ref_109","unstructured":"(2023, October 25). World Health Organization the Constitution. Available online: https:\/\/www.who.int\/about\/accountability\/governance\/constitution."},{"key":"ref_110","first-page":"3","article-title":"Holistic medicine: A new medical system based on body constitution and functional status","volume":"4","author":"Yuan","year":"2017","journal-title":"J. Tradit. Chin. Med. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","article-title":"The future of genetic studies of complex human diseases","volume":"273","author":"Risch","year":"1996","journal-title":"Science"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.shpsc.2009.09.006","article-title":"Causation and models of disease in epidemiology","volume":"40","author":"Broadbent","year":"2009","journal-title":"Stud. Hist. Philos. Biol. Biomed. Sci."},{"key":"ref_113","first-page":"24","article-title":"\u2018People with Problems, Not Patients with Illnesses\u2019: Using Psychosocial Frameworks to Reduce the Stigma of Psychosis","volume":"54","author":"Longdon","year":"2017","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"ref_114","unstructured":"(2023, October 17). World Health Organization Alcohol. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/alcohol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","article-title":"The Opioid Epidemic: Crisis and Solutions","volume":"58","author":"Skolnick","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_116","unstructured":"Huxley, A. (2021). The Doors of Perception, Strelbytskyy Multimedia Publishing."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"ref_118","unstructured":"Metzner, R. (1999). Ayahuasca: Hallucinogens, Consciousness, and the Spirit of Nature, Running Press."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02791072.1997.10400190","article-title":"Set, setting, and matrix","volume":"29","author":"Eisner","year":"1997","journal-title":"J. Psychoact. Drugs"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","article-title":"Tripping on nothing: Placebo psychedelics and contextual factors","volume":"237","author":"Olson","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2050324516683325","DOI":"10.1177\/2050324516683325","article-title":"Constructing drug effects: A history of set and setting","volume":"3","author":"Hartogsohn","year":"2017","journal-title":"Drug Sci. Policy Law"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_123","unstructured":"Soloman, D. (1966). LSD\u2014The Consciousness-Expanding Drug, Berkley Medallion Book."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"639124","DOI":"10.3389\/fphar.2021.639124","article-title":"Amazonian Medicine and the Psychedelic Revival: Considering the \u201cDieta\u201d","volume":"12","author":"Berlowitz","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"114910","DOI":"10.1016\/j.jep.2021.114910","article-title":"Teacher plants\u2014Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives","volume":"286","author":"Berlowitz","year":"2022","journal-title":"J. Ethnopharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/7942\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:33:23Z","timestamp":1760132003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/7942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":125,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["molecules28247942"],"URL":"https:\/\/doi.org\/10.3390\/molecules28247942","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]}}}